These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9719128

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 2000 Feb 01; 46(3):653-9. PubMed ID: 10701745
    [Abstract] [Full Text] [Related]

  • 5. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
    Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K, Akaboshi M, Kinashi Y, Abe M.
    Br J Radiol; 1997 Apr 01; 70(832):391-8. PubMed ID: 9166076
    [Abstract] [Full Text] [Related]

  • 6. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Kobayashi T, Takagaki M, Kinashi Y, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1999 May 01; 44(2):391-8. PubMed ID: 10760435
    [Abstract] [Full Text] [Related]

  • 7. Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction.
    Masunaga S, Ono K, Suzuki M, Sakurai Y, Takagaki M, Kobayashi T, Kinashi Y, Akaboshi M.
    J Cancer Res Clin Oncol; 1999 Nov 01; 125(11):609-14. PubMed ID: 10541967
    [Abstract] [Full Text] [Related]

  • 8. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Hiraoka M, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Anticancer Res; 2004 Nov 01; 24(5A):2975-83. PubMed ID: 15517904
    [Abstract] [Full Text] [Related]

  • 9. Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.
    Masunaga S, Ono K, Takahashi A, Sakurai Y, Ohnishi K, Kobayashi T, Kinashi Y, Takagaki M, Ohnishi T.
    Jpn J Cancer Res; 2002 Dec 01; 93(12):1366-77. PubMed ID: 12495477
    [Abstract] [Full Text] [Related]

  • 10. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S, Sakurai Y, Suzuki M, Nagata K, Maruhashi A, Kinash Y, Ono K.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):920-7. PubMed ID: 15465210
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Nagasawa H, Uto Y, Hori H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):996-1007. PubMed ID: 11572769
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
    Masunaga S, Nagasawa H, Gotoh K, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Radiat Med; 2006 Feb 01; 24(2):98-107. PubMed ID: 16715670
    [Abstract] [Full Text] [Related]

  • 13. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
    Masunaga S, Nagasawa H, Sakurai Y, Uto Y, Hori H, Nagata K, Suzuki M, Maruhashi A, Kinashi Y, Ono K.
    Int J Hyperthermia; 2006 Jun 01; 22(4):287-99. PubMed ID: 16754350
    [Abstract] [Full Text] [Related]

  • 14. Applicability of combination with tirapazamine in boron neutron capture therapy.
    Masunaga S, Ono K, Sakurai Y, Hori H, Kobayashi T, Takagaki M, Suzuki M, Kinashi Y, Akaboshi M.
    Jpn J Cancer Res; 1998 Jul 01; 89(7):768-74. PubMed ID: 9738984
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Jul 01; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 16. Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation.
    Masunaga S, Ono K, Suzuki M, Kinashi Y, Takagaki M.
    Int J Radiat Oncol Biol Phys; 2001 Apr 01; 49(5):1361-8. PubMed ID: 11286844
    [Abstract] [Full Text] [Related]

  • 17. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
    Masunaga S, Ono K, Kirihata M, Takagaki M, Sakurai Y, Kinashi Y, Kobayashi T, Suzuki M, Nagata K, Nagasawa H, Uto Y, Hori H.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):21-8. PubMed ID: 12618897
    [Abstract] [Full Text] [Related]

  • 18. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
    Masunaga SI, Sanada Y, Takata T, Tanaka H, Sakurai Y, Suzuki M, Kirihata M, Ono K.
    J Radiat Res; 2023 Mar 23; 64(2):399-411. PubMed ID: 36763853
    [Abstract] [Full Text] [Related]

  • 19. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
    Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Takagaki M.
    Jpn J Cancer Res; 1997 Aug 23; 88(8):770-7. PubMed ID: 9330609
    [Abstract] [Full Text] [Related]

  • 20. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H.
    Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.